CelLBxHealth plc carries a market capitalization of 31.70M, placing it among publicly traded companies globally.
| Market Cap | 31.70M |
| Enterprise Value | N/A |
CelLBxHealth plc's stock has declined approximately -74.95385% over the past 52 weeks. The 50-day moving average sits at 1.45, while the 200-day moving average is 1.37.
| Beta (5Y) | N/A |
| 52-Week Price Change | -74.95385% |
| 50-Day Moving Average | 1.45 |
| 200-Day Moving Average | 1.37 |
| Average Volume (20 Days) | N/A |